Lotte Bjerre Knudsen played a pivotal role in developing Ozempic and Wegovy. Now she wants to develop a once-a-year injection ...

Eli Lilly and Company (NYSE:LLY) is one of the Good Stocks to Buy Now. On March 20, Jefferies reiterated a Buy rating on Eli Lilly and Company (NYSE:LLY) with a price target of $1,300. ​The rating is ...

The FDA has some big verdicts lined up in the second quarter, including one for a closely watched obesity drug that many anticipate will further intensify competition in weight loss.

Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month ...

Dr Reddy's 'Olymviq' branded-drug has run into a legal wall owing to its similarity to Novo Nordisk's 'Ozempic' brand. In ...